openPR Logo
Press release

Genome Editing Market Size To Reach USD 15072.3 Million by 2025 | Top Key Players Sangamo Therapeutics, ToolGen, Vertex, CRISPR Therapeutics, Precision Biosciences, Oxford Genetics

09-22-2021 08:31 AM CET | Science & Education

Press release from: Brandessence Market Research

Global Genome Editing Market is valued at USD 5052.2 Million in 2020 and expected to reach USD 15072.3 Million by 2025 with the CAGR of 16.9% over the forecast period.

Global Genome Editing Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Rising number of technological advancements, increased focus on highly adaptable CRISPR technology and growing investment in research and development in this field by Government and private organization are anticipated to drive the growth of Global Genome Editing Market.

Get Sample Report:@ https://brandessenceresearch.com/requestSample/PostId/1635

Scope of Global Genome Editing Market Report:

Genome editing is a group of technologies that enables gene professionals to change an organism's DNA. These technologies enable genetic material to be added, altered or removed at particular location in the gene. Genome editing also referred as the gene editing. Genome editing has indicated a good potential for the treatment of genetic disorders, infectious disease and cancer. Genome editing is one of the great interests in the prevention and treatment of human diseases including understanding diseases using animal and cells models, to determine predicted approach is safe and effective for use in human.

Gene editing also being explored in research on a wide range of diseases, including single-gene disorders like hemophilia, cystic fibrosis and sickle cell diseases among others. It is capable to treatment and prevention of more critical disease including cancer, mental illness, heart disease, and human immunodeficiency virus (HIV) infection. The first genome editing advancements were developed in the last part of the 1900s. As recently, another genome editing tool called CRISPR, developed in 2009, has made it simpler than any time in recent memory to alter DNA. CRISPR is easier, quicker, less expensive, and more precise than older genome editing strategies. Numerous researchers who perform genome editing presently using CRISPR.

The COVID-19 pandemic has driven the demand in this space to develop fast molecular diagnostic tests dependent on gene editing by biotechnology organizations. During COVID-19 pandemic, research communities are exploring the capability of gene-modifications tools like CRISPR as a potential fast evaluating solution for the COVID-19 genome. For example; in December 2020, analysts from Gladstone Institutes fostered a CRISPR-based test that utilizes cell phones to convey results. Also, in June 2020, specialists from Stanford University have created - PAC-MAN a gene-modification tool dependent on CRISPR innovation. This tool destroys SARS-CoV-2 inside human cells. Hence, COVID-19 has shown a positive impact on the growth of global genome editing market.

Global genome editing market is segmented on the basis of technology, product & services, application, end-users and regional & country level. On the basis of technology, genome editing market is classified into (CRISPR)/Cas9, TALENs/MegaTALs, ZFN and others.

On the basis of product and services, the market is divided into reagents & consumables, software & systems and services. On the basis of application, genome editing service market is classified into cell line engineering, animal genetic engineering, plant genetic engineering and other applications. On the basis of end-users, genome editing market is classified into biotechnology companies, pharmaceutical companies and academic & government research institutes.

Global Genome Editing Market Segmentation:

By Technology:

(CRISPR)/Cas9
TALENs/MegaTALs
ZFN
Others

By Product & Services:

Reagents & Consumables
Software & Systems
Services

By Application:

Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other Applications

By End-Users:

Biotechnology Companies
Pharmaceutical Companies
Academic & Government Research Institutes

The regions covered in global genome editing market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of market of genome editing is sub divided in U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Genome Editing Market Report:

Global genome editing market reports cover prominent players like Sangamo Therapeutics, ToolGen, Vertex, CRISPR Therapeutics, Precision Biosciences, Oxford Genetics , Synthego, Vigene Biosciences, EpiGenie, Integrated DNA Technologies, New England Biolabs, OriGene Technologies, Lonza, GenScript, Eurofins Scientific, Editas Medicine, Intellia Therapeutics, Transposagen Biopharmaceuticals, Creative Biogene, Thermo Fisher Scientific, Merck, Horizon Discovery Limited, Agilent Technologies, DanaherCellecta, Genecopoeia, and Calyxt and others.

Get Methodology Report:@ https://brandessenceresearch.com/requestMethodology/PostId/1635

News: Vertex and Obsidian Entered Agreement to Develop Gene-Editing Treatments

On April 23rd, 2021; Vertex Pharmaceuticals (VRTX) and Obsidian Therapeutics entered a strategic research partnership and licensing agreement to discover and develop novel therapies that regulate gene editing for treating serious diseases. In this collaboration, Obsidian’s cytoDRiVE technology is used to develop novel regulated gene-editing therapy candidates whose therapeutic activity can be accurately controlled using small molecules.

Rising Number of Technological Advancements, Increased Focus on Highly Adaptable CRISPR Technology and Growing Investment in Research and Development in This Field by Government and Private Organization are Driving the Market growth

One of the major factors driving the growth of global genome editing market is increasing number of technological advancements. For instance; in April 2021, researchers from Wyss Institute for Biologically Inspired Engineering at Harvard created Retron Library Recombineering (RLR), another gene-editing tool that empowered the performance of millions of genetic experiments at the same time, accordingly giving better altering rates. In addition, increased focus on highly adaptable CRISPR technology is also supplementing the market growth. For instance; in April 2021, Vertex Pharmaceuticals paid USD 900 million to CRISPR Therapeutics to develop, produce and commercialize CRISPR-Cas9 gene-edited treatment for beta-thalassemia and sickle-cell sickness.

Furthermore, growing investment in research and development in this field by Government and private organization are also fostering the growth of the global genome editing market. For instance; in January 2018; U.S. government reported giving US$ 190 million for research for the following six years. Additionally, the government wants to develop treatments to treat cancer and different sicknesses utilizing gene editing. Likewise, the National Institutes of Health (NIH) has kept roughly US$ 45.5 million to the side for the following four monetary years for the Somatic Cell Genome Editing program.

However, high cost of genome equipments and ethical concerns regarding modifying an organism’s DNA may hamper the global genome editing market growth. In spite of that, rising focus on implementing preventive maintenance strategies between healthcare organizations and growing government support can offer more opportunities for the global genome editing market growth during the forecast period.

North America is Expected to Dominate Global Genome Editing Market

North America is expected to dominate the global genome editing service market due to the rising awareness about the growing prevalence of genome-related disorders, rising technological advancement and presence of key players in this region. For instance; as per the National Cancer Institute (NCI), in 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease. In 2019, Thermo Fisher Scientific acquired Brammer Bio to get to Brammer Bio's expertise in assembling vectors for genes and cell treatments. In October 2020, Scribe Therapeutics teamed up with Biogen for the advancement of CRISPR-based genetic medications for neurological illnesses like Amyotrophic Lateral Sclerosis.

Asia Pacific is expected to witness a fastest growth in the global genome editing market due to the rapid technological advancement, improved focus on highly adaptable CRISPR technology and growing investments made by market players and government in gene editing research in this region. For instance; in November 2020, China declared its ten most critical advances in the farming area, out of which one was gene-editing technology, accordingly addressing the high market entrance of this space in the country. In December 2020, Takara Bio authorized CRISPR genome editing innovation from Merck KGaA (Millipore Sigma). This agreement upgraded Takara's stem cell service abilities including the advancement of vectors.

Table of Content

Chapter 1 Global Genome Editing Market : Summary and Quantitative Analysis

1.1 Report Description
1.2 Global Genome Editing Market Revenue Overview
1.3 Global Genome Editing Market Revenue (USD Billion) and Growth (%) Rate, 2021-2027

Chapter 2 Global Genome Editing Market : Overview and Qualitative Analysis

2.1 Executive Summary
2.2 Market Drivers
2.3 Market Restraints
2.4 Market Opportunities
2.5 Market Trends
2.6 Global Genome Editing Market : SWOT Analysis
2.7 Global Genome Editing Market : PEST Analysis
2.8 Global Genome Editing Market : Attractiveness Analysis
2.8.1 Global Genome Editing Market : Attractiveness Analysis by Type
2.8.2 Global Genome Editing Market : Attractiveness Analysis by Application
2.8.3 Global Sterile Medical Packaging Market : Attractiveness Analysis by Regional

Chapter 3 Competitive Analysis

3.1 Global Genome Editing Market
3.1.1 Global Genome Editing Market Revenue (USD Billion), By Players 2018
3.1.2 Global Genome Editing Market Revenue Share (%), By Players 2018

Chapter 5 Global Genome Editing Market : By Types

5.1 Global Genome Editing Market Share (%), By Types, 2018
5.2 Global Genome Editing Market Revenue (USD Billion), By Types, 2021-2027
5.3 Global Genome Editing Market Revenue (USD Billion), T1 ,2021-2027
5.4 Global Genome Editing Market Revenue (USD Billion), T2,2021-2027
5.5 Global Genome Editing Market Revenue (USD Billion), T3,2021-2027
5.6 Global Genome Editing Market Revenue Share (%), By Types, 2021-2027
5.7 Global Genome Editing Market Revenue Market Share (%), By Types, 2021-2027

Chapter 6 Global Genome Editing Market : By Application

6.1 Global Genome Editing Market Share (%), By Application, 2018
6.2 Global Genome Editing Market Revenue (USD Billion), By Application, 2021-2027
6.3 Global Genome Editing Market Revenue (USD Billion), A1, 2021-2027
6.4 Global Genome Editing Market Revenue (USD Billion), A2, 2021-2027
6.5 Global Genome Editing Market Revenue (USD Billion), A3, 2021-2027
6.6 Global Genome Editing Market Revenue Share (%), By Application, 2021-2027
6.7 Global Genome Editing Market Revenue Market Share (%), By Application, 2021-2027

Chapter 7 North America Genome Editing Market Analysis

7.1 North America Market Snapshot
7.1.1 North America Genome Editing Market Revenue and Growth Rate (%), 2021-2027 .
7.1.2 North America Genome Editing Market Revenue (USD Billion) Overview, by Country, 2021-2027
7.1.3 North America Genome Editing Market Revenue (USD Billion) and Growth Rate (%), 2021-2027
7.1.4 North America Genome Editing Market Revenue (USD Billion) Overview, by Type, 2021-2027
7.1.5 North America Genome Editing Market Revenue (USD Billion) Overview, by Application , 2021-2027

Chapter 8 Europe Genome Editing Market Analysis

8.1 Europe Market Snapshot
8.1.1 Europe Genome Editing Market Revenue and Growth Rate (%), 2021-2027 .
8.1.2 Europe Genome Editing Market Revenue (USD Billion) Overview, by Country, 2021-2027
8.1.3 Europe Genome Editing Market Revenue (USD Billion) and Growth Rate (%), 2021-2027
8.1.4 Europe Genome Editing Revenue (USD Billion) Overview, by Type, 2021-2027
8.1.5 Europe Genome Editing Revenue (USD Billion) Overview, by Application, 2021-2027

Get Full Report @ https://brandessenceresearch.com/healthcare/genome-editing-market-size

Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com

About us: Brandessence Market Research and Consulting Pvt. Ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genome Editing Market Size To Reach USD 15072.3 Million by 2025 | Top Key Players Sangamo Therapeutics, ToolGen, Vertex, CRISPR Therapeutics, Precision Biosciences, Oxford Genetics here

News-ID: 2401831 • Views: 762

More Releases from Brandessence Market Research

Industrial Air Filtration Market 2021 Size, Leading Players, Share Industry Tren …
Global Industrial Air Filtration Market to reach USD xx billion by 2025. Global Industrial Air Filtration Market valued approximately USD xx billion in 2016 is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2017-2025. Industrial Air Filtration Market Research Report is a proficient and In-Depth Study on the Existing State of Industrial Air Filtration Industry. This Report Focuses on the Major
Restaurant Management Software Market Size, Share, Application Analysis, Latest …
Global Restaurant Management Software Market to reach USD 6.95 billion by 2025. Global Restaurant Management Software Market valued approximately USD 14.3 billion in 2016 is anticipated to grow with a healthy growth rate of more than 14.89% over the forecast. Restaurant Management Software Market Research Report is a proficient and In-Depth Study on the Existing State of Restaurant Management Software Industry. This Report Focuses on the Major Drivers, Restraints, Opportunities and
Pharmacovigilance and Drug Safety Software Market Size, Industry Analysis Report …
Global Pharmacovigilance and Drug Safety Software Market to reach USD 265.2 billion by 2025. Global Pharmacovigilance and Drug Safety Software Market valued approximately USD 150.4 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast Year. Pharmacovigilance and Drug Safety Software Market Research Report is a proficient and In-Depth Study on the Existing State of Pharmacovigilance and Drug Safety Software Industry.
Europe Celiac Disease diet Market Challenges, Restraint, Bussiness Oppertunity W …
Brandessence Market Research is working on a new report title “Europe Celiac Disease diet Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Increasing prevalence of celiac diseases & gluten allergies and growing awareness among people are key drivers for Europe Celiac Disease Diet Market. Coronavirus pandemic has gripped many corners of the global economy. As the pandemic Alters our economic life, it is important to track this development

All 5 Releases


More Releases for Genome

Digital Genome Market: Growing Funding for Genomics
Genomic sequencing technology is rapidly transitioning into clinical practice, and implementation of the same into healthcare systems has been supported by substantial government investment, accounting for ~US$ 4 billion in at least 14 countries. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implement and gather evidence for broader adoption, thereby driving the market growth. The digital genome market was valued at US$ 11,065.31
Genome Editing Market Bringing In impressive Revenues
Genome editing is a technique in genetic engineering that involves inserting, deleting or replacing a DNA into the desired locations into a genome of the living organism to change the phenotype of the organism. Genome editing plays a very significant role in modern day biology and is widely used in biotechnology and biopharmaceutical industry to alter the genome of microorganisms to perform process like the fermentation which yield desired products
Genome Editing Market tremendous demand till 2025
Global Genome Editing Market: Overview Also known as genome editing with engineered nucleases (GEEN), genome editing is a method of altering DNA within a cell in a safe manner. The technique is also used for removing, adding, or modifying DNA in the genome. By thus editing the genome, it is possible to change the primary characteristic features of an organism or a cell. The global genome editing market can be
Genome Editing Market Growth Analysis by 2025
Genome editing is a technique in genetic engineering that involves inserting, deleting or replacing a DNA into the desired locations into a genome of the living organism to change the phenotype of the organism. Genome editing plays a very significant role in modern day biology and is widely used in biotechnology and biopharmaceutical industry to alter the genome of microorganisms to perform process like the fermentation which yield desired products
Genome Engineering Market - Global Industry Analysis 2025
Genome engineering is a process of insertion, deletion, modification or replacement of DNA bases in an organism. Genome engineering has exhibited potential benefits in gene therapy. For instance, various genetic disorders such as Hemophilia, Myotonic dystrophy, Alzheimer’s disease, Sickle cell anemia, Gaucher disease, Cystic fibrosis (involves correction of a single gene) or asthma, autoimmune diseases, cancer, diabetes, and heart disease (involves correction of multiple genes) can be treated using genomic
Genome Engineering Market Analysis & Key Trends 2023
“To develop innovative, technologically advanced and differentiated products, the leading companies are banking on agreements with laboratories and research institutes and pouring funds into ongoing research and development projects,” says the author of the report. The global genome engineering market is anticipated to reach a valuation of US$7.21 bn by 2023 from US$2.30 bn in 2015, expanding at a remarkable CAGR of 14.2% from 2015 to 2023. Increasing Funding by Biotechnology